Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nightingale HealthNGHLF 63 Debt-to-Equity is 0.08 as of Dec. 2025, which is 33% above its 10-year median of 0.06. GuruFocus rates NGHLF with a GF Score™ of 63/100 and a GF Value™ of $3.53. The stock has 6 warning signs investors should review. Among 556 Healthcare Providers & Services companies, Nightingale Health ranks better than 81.65% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Nightingale Health's Debt-to-Equity or its related term are showing as below:
NGHLF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.06 Max: 1.81
Current: 0.08
During the past 7 years, the highest Debt-to-Equity Ratio of Nightingale Health was 1.81. The lowest was 0.02. And the median was 0.06.
NGHLF's Debt-to-Equity is ranked better than 81.65% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs NGHLF: 0.08
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Nightingale Health Debt-to-Equity Related Terms
Nightingale Health Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Nightingale Health's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGHLF vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, Nightingale Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nightingale Health Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Nightingale Health's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nightingale Health (NGHLF) has a Debt-to-Equity of 0.08 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Nightingale Health and its competitors. This is 33% above median its historical median of 0.06. Over the past decade, Nightingale Health's Debt-to-Equity has ranged from 0.02 to 1.81. According to the industry distribution chart, Nightingale Health ranks #102 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 18.3%.
Is Nightingale Health's Debt-to-Equity too high?
Nightingale Health's current Debt-to-Equity of 0.08 is 33% above median its 10-year median of 0.06. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 1.81. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Nightingale Health's value of 0.08 is 81% below this industry median. Based on the distribution chart, Nightingale Health ranks #102 out of 556 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nightingale Health has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #102 out of 556 companies for Debt-to-Equity. This places Nightingale Health in the top 18% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.42. Nightingale Health's value of 0.08 is 81% below this benchmark. Historically, Nightingale Health's own Debt-to-Equity has ranged from 0.02 to 1.81 over the past decade. While the company's 10-year median is 0.06 vs. the industry median of 0.42, Nightingale Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nightingale Health's current Debt-to-Equity of 0.08 is 81% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Nightingale Health and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current Debt-to-Equity is 0.08, which is 33% above median its own 10-year median of 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Nightingale Health (NGHLF) has a current Debt-to-Equity of 0.08. The stock's GF Value™ is $3.53, compared to a current price of $1.19 — trading 66.3% below its estimated fair value. The current Debt-to-Equity is 0.08, which is 33% above median its 10-year median of 0.06 and 81% below the Healthcare Providers & Services industry median of 0.42. Nightingale Health's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current Debt-to-Equity is 0.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nightingale Health (NGHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued.
The current stock price of $1.19 is trading 66.3% below its estimated GF Value™ of $3.53.
Key valuation signals for NGHLF:
Debt-to-Equity: 0.08 (33% above median its 10-year median of 0.06)
GF Value™: $3.53 vs. price of $1.19 (66.3% below fair value)
Industry Position: 81% below the Healthcare Providers & Services median (#102 of 556)
No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
63GF Score
Get the complete analysis for NGHLF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGHLF has been successfully added to your 
